Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1517
https://www.valueinhealthjournal.com/article/S1098-3015(17)31851-X/fulltext
Title : Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31851-X&doi=10.1016/j.jval.2017.08.1517
First page : A650
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1366
Categories :
Tags :
Regions :
ViH Article Tags :